Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2025-12-24 @ 7:23 PM
NCT ID:
NCT05466903
Eligibility Criteria:
Inclusion Criteria:
* Age 18-75, no gender restrictions,
* Patients with colonic polyps identified by colonoscopy and requiring endoscopic treatment,
* Polyp size 0.5cm-2cm,
* Patients agreed to enroll and signed a written informed consent,
* Adherence is good and agrees to be treated and evaluated as required by the study protocol.
Exclusion Criteria:
* Patients with contraindications to endoscopic treatment of colonic polyps, including platelets ≤50×109/L, prothrombin time prolonged by 4 seconds or more, and INR≥2.0,
* Patients with severe heart, brain, lung, blood system diseases, uremia, connective tissue disease,
* Patients requiring treatment with NSAIDs, aspirin, glucocorticoids, or clopidogrel within the first 7 days of the study,
* During the course of the study, due to other concomitant/complications, patients who need to use drugs that affect the efficacy of the trial, including various anticoagulants, antiplatelet drugs and hemostatic drugs,
* Alcoholics, drug addicts or those with uncontrollable neuropsychiatric diseases and others who are not suitable for participating in the trial,
* Pregnant, breastfeeding women, or women in childbearing age who wish to become pregnant,
* Patients with malignant tumor of digestive system,
* Other circumstances in which the investigator believes that the patient should not participate in this trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05466903
Study Brief:
Protocol Section:
NCT05466903